NCT00691717

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 201 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Conditions

• Open-angle Glaucoma
• Oular Hypertension

Interventions

Type	Name	Description
DRUG	Anecortave Acetate Sterile Suspension, 30 mg/mL	Single administration by anterior juxtascleral depot
DRUG	Anecortave Acetate Sterile Suspension, 60 mg/mL	Single administration by anterior juxtascleral depot
DRUG	Anecortave Acetate Sterile Suspension, 75 mg/mL	Single administration by anterior juxtascleral depot
OTHER	Anecortave Acetate Vehicle	Single administration by anterior juxtascleral depot

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-09-01
• Completion: 2009-09-01
• First posted: 2008-06-05
• Last updated: 2012-11-28

Locations

1 site across 1 country: United States